Dengue Academy’s Post

The Trivitron Biocard® Dengue NS1 test kit is a diagnostic tool used for the rapid detection of dengue fever. It's designed to identify the presence of the NS1 antigen, a protein produced by the dengue virus, in a patient's blood sample. These test kits are commonly used in areas where dengue fever is prevalent or during outbreaks for quick identification and management of cases. The rapid detection provided by such kits enables healthcare professionals to initiate appropriate treatment promptly, improving patient outcomes. The Trivitron Dengue NS1 ELISA test kit is a diagnostic tool used for the detection of Dengue virus NS1 antigen in human serum. This test kit is commonly utilized in clinical laboratories and healthcare settings to aid in the diagnosis of Dengue fever, particularly during the early stages of infection. To learn more https://lnkd.in/g4ZgYSpp or call us at 9840080008. #ELISA #DengueNS1TestKit #MosquitoBite #Platelets #Blood #Immunity #LowPlateletCount #DengueTest #VectorBornInfection #MosquitoBornDiseases #Trivitron #TrivitronHealthcare #Dengue #DengueVirus #DENV

COVID-19 is surging again this summer, with the CDC updating guidance on Oseltamivir for new flu strains. Despite the rise in cases, mortality rates remain steady, and recent variants aren’t expected to impact vaccine effectiveness. Stay informed about fluctuations in flu and COVID-19 rates seasonally and best clinical practices to keep patients safe with this article from the TeamHealth Emerging Infectious Disease Taskforce: https://bit.ly/3SRLGuE

THANK YOU FOR TOP FAN.! With President Joe Biden – I just got recognized as one of their top fans.! ARTICLE: CRYPTOCURRENCY & REYGITONIUM-G. MICHAEL BLOOMBERG FORMER NYC MAYOR Co-FOUNDER BLOOMBERG L.P MIKEBLOOMBERG.com CHAN ZUCKERBERG INITIATIVE CHANZUCKERBERG.com BILL & MELINDA GATES FOUNDATION GATESFOUNDATION.org TENRI CULTURAL INSTITUTE tenri.org https://lnkd.in/e55sRd8b https://lnkd.in/eB98Jnv9 WonderMind.com: CRYPTO-FINANCE & WHAT'S ON THE TABLE. REYGITONIUM-G MR. MS. TEEFEY & SELENA GOMEZ-RARE-SUPERSTAR. TCI GALLERY SPRING 2024 THEMES. CRYPTOCURRENCY & REYGITONIUM-G TO WHOM IT MAY CONCERN: I ABSOLUTELY SEE NOTHING WRONG WITH CRYPTOCURRENCY: REYGITONIUM-G I CAN UNDERSTAND WHY THE INFANT DEMOCRATIC-CAPITALISTIC MINDS OF TODAY BLAME USA GOVERNMENT. THEN IS ANY GOVERNMENT TO BE BLAMED FOR HOMELESS PROBLEMS PLAGUING THE WORLD.? NO. GOD KNOWS HEADACHES USA GOVERNMENT HAVE WITH THE FOREIGN AFFAIRS. THE NEW WORLD PRACTICALLY SHOCK TO WITNESS. PEOPLE ONLY WORKING TOGETHER FOR A COMMON GOAL. "IN THE PURSUIT OF HAPPINESS." THUS DOESN'T THAT ALSO INCLUDE THE HOMELESS. THE HOMELESS ARE OUT THERE. ARE YOU.? HOMELESS.. AN OPPORTUNITY MISUNDERSTOOD. The modern economic system is a market economy, which is a capitalist economy where people, not the government--NOT THE GOVERNMENT--own most businesses. In a capitalist economy, prices allocate capital and labor between competing uses, and capital assets like factories, mines, and railroads can be privately owned and controlled. https://lnkd.in/eB98Jnv9 GOOGLE EXAMPLE, IF YOU NEED TO RAISE MONEY FOR ANY REASON OR MORE SO LETS SAY THE "HOMELESS" PROBLEM WHICH IS BELIEVED TO BE TIME & MONEY CONSUMING BUT IN ONE DIRECTION TOWARD THE HOMELESS. HOWEVER CRYPTOCURRENCY CAN POSSIBLE ALLOWS AN EXPENDITURE OF CURRENCY TO BENEFIT ALL WHO USES THE CRYPTO & REGARDLESS OF HOW IT'S CONSUMED. THEREFORE IF A CRYPTO HOMELESS CURRENCY REYGITONIUM-G EXISTED IT'S MORE HIGHLY LIKELY THAT THE HOMELESS PROBLEM CAN BE VANQUISHED BECAUSE CURRENCY-FINANCES IT'S ALWAYS AVAILABLE TO BE TAPPED INTO FOR HOMELESS RESOLUTIONS. REYGITONIUM-G: EACH COUNTRY GOVERNMENT INITIAL $1-DOLLAR INVESTMENT PORTFOLIO OF 8-BILLION EARTH CITIZENS. THEREAFTER GLOBALLY ANYBODY CAN INVEST IN THE CRYPTOCURRENCY REYGITONIUM-G. OR CONTINUE HIDING THE HOMELESS WHEN A POLITICAL LEADER VISITS AMERICA. CLOSING COMMENT: THE DAMNEDEST CRAZIEST FUNNIEST EMBARRASSING ABOUT THE HOMELESS CHAOS IS ANY EXCUSE AS TO WHY HOMELESS EXIST. HENCEFORTH CONSIDER USA TRILLIONS IN DEBT & 6,120 HOSPITALS SCATTERED AROUND THE USA & MANY COUNTRIES ASKING FOR FOREIGN AID IN THE TRILLIONS & YOU TALKING EXCUSES. MEANWHILE WE WANT TO SETTLE HUMANITY ON OTHER PLANETS. THANK YOU FOR READING.

🚨 Important Update on Parvovirus B19 Outbreak: What You Should Know 🚨 With recent outbreaks of Parvovirus B19 reported in France and with the U.S. Centers for Disease Control and Prevention (CDC) issuing a Health Alert Network (HAN) Health Advisory, it is crucial that we stay informed about the potential impacts of Parvovirus B19 on public health, especially as the virus primarily affects pregnant women and individuals with chronic anemia or weakened immunity. 📊 The current outbreaks underscore the need to strengthen public health responses and preventative measures. Given that the virus can cause severe complications in pregnant women and individuals with chronic anemia or weakened immunity, it is important to recognize symptoms early to prevent these severe outcomes. A study on parvovirus B19 in blood donors by Dr SWATI KUMARI and I at the Department of Microbiology at Sri Ramachandra Institute of Higher Education and Research was recently published in Scientific Reports. This study highlighted the need to routinely screen blood and blood products before transfusion to high-risk individuals and possibly introduce routine blood screening for parvovirus B19. The study emphasized the significance of early detection and highlighted the unusually high prevalence of antibodies within a healthy donor population. Thank you, Dr. Padma Srikanth, for the guidance & mentorship. 🧬 For those interested in reading the article: https://lnkd.in/gSSrG8bZ #ParvovirusB19 #PublicHealth #VirusOutbreak #Diagnostics #Immunology #Preparedness

Measles and rubella continue to pose global health threats, despite the availability of safe vaccines. As part of the Centers for Disease Control and Prevention (CDC), we conducted a comprehensive review of population immunity against these diseases, analyzing hundreds of research articles from the past decade. We also give a perspective of related methodologies and the advantages of standardized, multiplex serology assays. A big shoutout to all the brilliant scientists involved in this vital project, with special recognition to Stephen Crooke, Ph.D., and Allison Brady for their exceptional leadership. For more details on our insightful review article, click here: https://lnkd.in/eJAUGPst

Thinking about diving into some important studies this Immunisation Week? Let's team up and tackle diseases head-on. Check out what studies we have and let's make a difference together! 💪 RESPECCT Respiratory syncytial virus and S. pneumoniae Challenge coinfection study: https://lnkd.in/gj6U23rd: https://lnkd.in/gj6U23rd BIO-004 Understanding how the immune system responds to repeated malaria infections: https://lnkd.in/dDhbp_cs NIV001 A study of a new vaccine against Nipah Virus: https://lnkd.in/eNePS-yK BIO-001: A challenge study to investigate whether a novel vaccine can prevent malaria: https://lnkd.in/dSxfBMbJ University of Oxford | Oxford University Department of Paediatrics #WorldImmunisationWeek #VaccinesWork #Research

DengueTcP is one of Emergex’s T cell-priming vaccine core products. DengueTcP is designed to protect against all 4 dengue infection-causing virus serotypes (DENV1, DENV2, DENV3, DENV4) by ‘priming’ T cells for rapid and robust response at subsequent infection. As globally reported cases of dengue fever have hit record numbers this year - with some developing into severe dengue – and approximately half the world’s population now at risk of dengue infection, there is an increasingly dire need to have accessible, universally safe and effective vaccine solutions against dengue. Learn more about DengueTcP here! https://bit.ly/4dPW6DW #Emergex #InfectiousDisease #ID # TCell

'Endemic' SARS-CoV-2 and the death of public health   "SARS-CoV-2 is now circulating out of control worldwide. The only major limitation on transmission is the immune environment the virus faces. The disease it causes, COVID-19, is now a risk faced by most people as part of daily life.""After HIV, SARS-CoV-2 is now the second most dangerous infectious disease agent that is 'endemic' to the human population on a global scale. And yet not only was it allowed to become endemic, but mass infection was outright encouraged, including by official public health bodies in numerous countries." "Infection, rather than vaccination, was the preferred route for many in public health in 2020, and still is in 2023, despite all that is known about this virus’s propensity to cause damage to all internal organs, the immune system, and the brain, and the unknowns of postinfectious sequelae. This is especially egregious in infants, whose naive immune status may be one of the reasons they have a relatively high hospitalization rate." https://lnkd.in/enq8NUFk  

Hospital admissions for COVID-19 are higher than they’ve been in about a year with thousands of new admissions every week. Helix's Head of Infectious Diseases, Shishi Luo, spoke with U.S. News & World Report’s Cecelia Smith-Schoenwalder to offer insights into the current winter #COVID wave in the United States and highlight the benefits #vaccines present among older populations. Luo says that Helix’s data shows that the benefits of COVID-19 vaccines are the greatest among older populations and that future vaccine campaigns might be more targeted to that age group. “What seems like a likely scenario is that booster campaigns would primarily focus on older adults … and then for the rest of the population, it may not be as high a priority to get boosted every year,” Luo says. Read more here: https://lnkd.in/gMtVV29m #CDC #longCOVID #healthcare